Download PDF

Other users also viewed these articles

Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;
Reumatol Clin. 2022;18:33-41
Gastrointestinal symptoms in patients using methotrexate: A cross-sectional study in a sample with rheumatoid arthritis Carina Albuquerque Roberto; Isabela Stachevski; Barbara Stadler Kahlow; Renato Nisihara; Thelma Skare;
Reumatol Clin. 2024;20:403-8
Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice Andrea de Diego-Sola; Agustín Castiella Eguzkiza; Luis María López Domínguez; Iratxe Urreta Barallobre; María José Sánchez Iturri; Joaquín María Belzunegui Otaño; Eva María Zapata Morcillo;
Reumatol Clin. 2023;19:412-6